HALOZYME THERAPEUTICS, INC. Shares Outstanding (Cover Page)
HALOZYME THERAPEUTICS, INC. (HALO) had Shares Outstanding (Cover Page) of 113.50 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 113.50M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 118.61M shares.
- 2026-02-10: Entity Common Stock, Shares Outstanding 118.02M shares.
- 2025-10-27: Entity Common Stock, Shares Outstanding 117.60M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 113.50M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 118.61M shares 10-Q · filed 2026-05-11 |
| 2026-02-10 | 118.02M shares 10-K · filed 2026-02-17 |
| 2025-10-27 | 117.60M shares 10-Q · filed 2025-11-03 |
| 2025-07-31 | 116.97M shares 10-Q · filed 2025-08-05 |
| 2025-04-30 | 123.22M shares 10-Q · filed 2025-05-06 |
| 2025-02-11 | 123.15M shares 10-K · filed 2025-02-18 |
| 2024-10-24 | 127.23M shares 10-Q · filed 2024-10-31 |
| 2024-07-31 | 126.68M shares 10-Q · filed 2024-08-06 |
| 2024-04-30 | 127.27M shares 10-Q · filed 2024-05-07 |
| 2024-02-12 | 126.82M shares 10-K · filed 2024-02-20 |
| 2023-10-31 | 132.10M shares 10-Q · filed 2023-11-06 |
| 2023-07-31 | 131.92M shares 10-Q · filed 2023-08-08 |
| 2023-04-28 | 131.68M shares 10-Q · filed 2023-05-09 |
| 2023-02-14 | 135.37M shares 10-K · filed 2023-02-21 |
| 2022-10-31 | 135.21M shares 10-Q · filed 2022-11-08 |
| 2022-08-02 | 137.78M shares 10-Q · filed 2022-08-09 |
| 2022-05-04 | 137.95M shares 10-Q · filed 2022-05-10 |
| 2022-02-14 | 137.70M shares 10-K · filed 2022-02-22 |
| 2021-10-25 | 140.79M shares 10-Q · filed 2021-11-02 |
| 2021-08-03 | 142.33M shares 10-Q · filed 2021-08-09 |
| 2021-05-05 | 142.39M shares 10-Q · filed 2021-05-10 |
| 2021-02-17 | 135.28M shares 10-K · filed 2021-02-23 |
| 2020-10-28 | 135.18M shares 10-Q · filed 2020-11-02 |
| 2020-08-05 | 137.03M shares 10-Q · filed 2020-08-10 |
| 2020-05-06 | 135.81M shares 10-Q · filed 2020-05-11 |
| 2020-02-14 | 138.23M shares 10-K · filed 2020-02-24 |
| 2019-11-07 | 146.54M shares 10-Q · filed 2019-11-12 |
| 2019-07-31 | 146.31M shares 10-Q · filed 2019-08-06 |
| 2019-04-30 | 145.51M shares 10-Q · filed 2019-05-07 |
| 2019-02-14 | 145.03M shares 10-K · filed 2019-02-21 |
| 2018-10-30 | 144.56M shares 10-Q · filed 2018-11-06 |
| 2018-07-31 | 144.30M shares 10-Q · filed 2018-08-07 |
| 2018-05-03 | 143.97M shares 10-Q · filed 2018-05-10 |
| 2018-02-13 | 143.08M shares 10-K · filed 2018-02-20 |
| 2017-11-01 | 142.36M shares 10-Q · filed 2017-11-07 |
| 2017-08-01 | 141.92M shares 10-Q · filed 2017-08-08 |
| 2017-05-01 | 129.84M shares 10-Q · filed 2017-05-09 |
| 2017-02-22 | 129.76M shares 10-K · filed 2017-02-28 |
| 2016-11-01 | 129.49M shares 10-Q · filed 2016-11-07 |
| 2016-08-02 | 129.41M shares 10-Q · filed 2016-08-09 |
| 2016-05-02 | 129.14M shares 10-Q · filed 2016-05-09 |
| 2016-02-22 | 129.06M shares 10-K · filed 2016-02-29 |
| 2015-11-02 | 128.01M shares 10-Q · filed 2015-11-09 |
| 2015-08-06 | 12.77M shares 10-Q · filed 2015-08-10 |
| 2015-05-06 | 127.26M shares 10-Q · filed 2015-05-11 |
| 2015-02-24 | 126.70M shares 10-K · filed 2015-03-02 |
| 2014-11-05 | 125.39M shares 10-Q · filed 2014-11-10 |
| 2014-08-05 | 125.31M shares 10-Q · filed 2014-08-11 |
| 2014-05-05 | 124.51M shares 10-Q · filed 2014-05-12 |
| 2014-02-24 | 124.00M shares 10-K · filed 2014-02-28 |
| 2013-11-04 | 114.03M shares 10-Q · filed 2013-11-08 |
| 2013-08-05 | 113.29M shares 10-Q · filed 2013-08-07 |
| 2013-05-06 | 113.16M shares 10-Q · filed 2013-05-08 |
| 2013-02-25 | 113.12M shares 10-K · filed 2013-03-01 |
| 2012-10-31 | 112.71M shares 10-Q · filed 2012-11-08 |
| 2012-08-01 | 112.69M shares 10-Q · filed 2012-08-09 |
| 2012-04-30 | 112.44M shares 10-Q · filed 2012-05-07 |
| 2012-03-01 | 112.09M shares 10-K · filed 2012-03-12 |
| 2011-11-02 | 103.69M shares 10-Q · filed 2011-11-08 |
| 2011-08-01 | 103.62M shares 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |